OncoTracker
Business Services · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
9201 W Sunset Blvd Ste 300, West Hollywo...Phone Number
(424) 204-0734Website
www.oncotracker.comRevenue
$5.5 MillionIndustry
About OncoTracker
ONCOtracker is a leading innovation center specializing in cancer treatment and testing, particularly for multiple myeloma and other B-cell malignancies. The company offers exclusive clinically validated ELISA sBCMA testing services, myeloma patient-derived tumor cell lines for drug discovery, and maintains a large onsite biobank for related research. Founded by Dr. James R. Berenson, a prominent researcher in multiple myeloma, ONCOtracker focuses on precision medicine and developing innovative therapies to enhance patient outcomes. Their services are aimed at clinical and research institutions looking to enhance drug evaluation and treatment options for cancer patients.Explore more
OncoTracker Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to OncoTracker
Compare insights from companies similar to OncoTracker, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
OncoTracker Tech Stack
A closer look at the technologies used by OncoTracker
See more technologies
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding OncoTracker
Sign Up For FreeTo access detailed company insights
ONCOtracker is a leading innovation center specializing in cancer treatment and testing, particularly for multiple myeloma and other B-cell malignancies. The company offers exclusive clinically validated ELISA sBCMA testing services, myeloma patient-derived tumor cell lines for drug discovery, and maintains a large onsite biobank for related resear... Read More
